Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients: a Multi-center, Prospective, Randomized, Open-labeled, Blinded Endpoints Trial

NCT00863980 is registered in ClinicalTrials.gov with Kyoto Prefectural University of Medicine as lead sponsor.

NCT NCT00863980
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00863980 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Telmisartan Compared With Candesartan on Ischemic Cardiovascular Events in High-risk Hypertensive Patients: a Multi-center, Prospective, Randomized, Open-labeled, Blinded Endpoints Trial
Lead sponsor
Kyoto Prefectural University of Medicine
Phase
Not applicable
Overall status
Terminated
Start date
April 30, 2009
Completion date
July 31, 2013
Enrollment
1,500 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, acute myocardial infarction, angina pectoris, hypertension, myocardial ischemia